메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한암학회 Cancer Research and Treatment Cancer Research and Treatment 제47권 제4호
발행연도
2015.1
수록면
697 - 705 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose This study was conducted to validate the survival benefit of metastasectomy pluschemotherapy over chemotherapy alone for treatment of Krukenberg tumors from gastriccancer and to identify prognostic factors for survival. Materials and MethodsClinical data from 216 patients with Krukenberg tumors from gastric cancer were collected. Patients were divided into two arms according to treatment modality: arm A, metastasectomyplus chemotherapy and arm B, chemotherapy alone. ResultsOverall survival (OS) was significantly increased in arm A relative to arm B for patients initiallydiagnosed with stage IV gastric cancer (18.0 months vs. 8.0 months; p < 0.001) and thosewith recurrent Krukenberg tumors (19.0 months vs. 9.0 months; p=0.002), respectively. Metastasectomy (hazard ratio [HR], 0.458; 95% confidence interval [CI], 0.287 to 0.732;p=0.001), signet-ring cell pathology (HR, 1.583; 95% CI, 1.057 to 2.371; p=0.026), andperitoneal carcinomatosis (HR, 3.081; 95% CI, 1.610 to 5.895; p=0.001) were significantprognostic factors for survival. ConclusionMetastasectomy plus chemotherapy offers superior OS when compared to palliativechemotherapy alone in gastric cancer with Krukenberg tumor. Prolonged survival appliesto all patients, regardless of gastric cancer stage. Metastasectomy, signet-ring cell pathology,and peritoneal carcinomatosis were prognostic factors for survival. Future prospectiverandomized trials are needed to confirm the optimal treatment strategy for Krukenbergtumors from gastric cancer.

목차

등록된 정보가 없습니다.

참고문헌 (25)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0